Loading...
Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas
BRAF(V600E) is a common finding in glioma (about 10–60% depending on histopathologic subclassification). BRAF(V600E) monotherapy shows modest preclinical efficacy against BRAF(V600E) gliomas and also induces adverse secondary skin malignancies. Here, we examine the molecular mechanism of intrinsic r...
Na minha lista:
| Udgivet i: | J Neurooncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5560871/ https://ncbi.nlm.nih.gov/pubmed/27848137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2333-4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|